Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to content
Huub Schellekens

Country

The Netherlands

Biography

Professor Dr Huub Schellekens is Director of the Central Laboratory Animal Institute of the University of Utrecht, The Netherlands, and Professor of Medical Biotechnology in the Department of Innovation Studies and Pharmaceutical Sciences. Prior to his present position, he was Deputy Director of the Dutch Primate Center, Director of Medscand Ingeny and Medical Microbiologist at the Reinier de Graaf Hospital in Delft, The Netherlands.
Professor Schellekens' research interests include the preclinical development of biopharmaceutical agents and applications of genetic modification in medicine. He studied medicine at the Erasmus University in Rotterdam, The Netherlands (1967–1973), where he also received his training in Medical Microbiology (1973–1980), completing his PhD in 1980. Between 1992 and 1997, Professor Schellekens coordinated an EU concerted action on the antigenicity of r-DNA-derived pharmaceuticals. He was Chairman of The Netherlands Commission on Genetic Modification and is Deputy Chairman of the Commission on Biotechnology and Animals. Professor Schellekens is also a member of the Dutch Medical Evaluation Board and a National Expert for the European Medical Evaluation Agency. He has authored over 200 scientific publications, eight non-specialist books and numerous articles in the popular press. He also contributes regularly to radio and television broadcasts.
 

×
×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.